{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:18:31Z","timestamp":1768828711068,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":908,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F32DK121423"],"award-info":[{"award-number":["F32DK121423"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES017537"],"award-info":[{"award-number":["R01ES017537"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["T32ES007255"],"award-info":[{"award-number":["T32ES007255"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1002\/rth2.12403","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T19:50:40Z","timestamp":1593114640000},"page":"906-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Liver fibrosis is driven by protease\u2010activated receptor\u20101 expressed by hepatic stellate cells in experimental chronic liver injury"],"prefix":"10.1016","volume":"4","author":[{"given":"Lauren G.","family":"Poole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4468-8639","authenticated-orcid":false,"given":"Asmita","family":"Pant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly M.","family":"Cline\u2010Fedewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan L.","family":"Copple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Luyendyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1002\/rth2.12403_bb0010","doi-asserted-by":"crossref","first-page":"G171","DOI":"10.1152\/ajpgi.00402.2017","article-title":"Role of the blood coagulation cascade in hepatic fibrosis","volume":"315","author":"Pant","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1002\/rth2.12403_bb0015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2006.08.023","article-title":"Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat","volume":"46","author":"Abe","year":"2007","journal-title":"J Hepatol"},{"issue":"4","key":"10.1002\/rth2.12403_bb0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2015.12.003","article-title":"Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats","volume":"64","author":"Cerini","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1002\/rth2.12403_bb0025","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/hep.29084","article-title":"The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells","volume":"65","author":"Vilaseca","year":"2017","journal-title":"Hepatology"},{"issue":"8","key":"10.1002\/rth2.12403_bb0030","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1538-7836.2008.03015.x","article-title":"Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies","volume":"6","author":"Anstee","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1002\/rth2.12403_bb0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12876-018-0789-8","article-title":"Thrombin and factor Xa link the coagulation system with liver fibrosis","volume":"18","author":"Dhar","year":"2018","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1002\/rth2.12403_bb0040","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"issue":"45","key":"10.1002\/rth2.12403_bb0045","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.3748\/wjg.v17.i45.5007","article-title":"Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation","volume":"17","author":"Maharshak","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1002\/rth2.12403_bb0050","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jhep.2015.07.026","article-title":"Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population: the Rotterdam Study","volume":"63","author":"Plompen","year":"2015","journal-title":"J Hepatol"},{"issue":"8","key":"10.1002\/rth2.12403_bb0055","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"issue":"22","key":"10.1002\/rth2.12403_bb0060","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1182\/blood-2015-09-670703","article-title":"Fibrin deposition following bile duct injury limits fibrosis through an alphaMbeta2\u2010dependent mechanism","volume":"127","author":"Joshi","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1002\/rth2.12403_bb0065","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0016-5085(95)90211-2","article-title":"Accumulation and cellular localization of fibrinogen\/fibrin during short\u2010term and long\u2010term rat liver injury","volume":"108","author":"Neubauer","year":"1995","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/rth2.12403_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cld.2008.09.013","article-title":"Parenchymal extinction: coagulation and hepatic fibrogenesis","volume":"13","author":"Anstee","year":"2009","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1002\/rth2.12403_bb0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/jth.14330","article-title":"Chronic liver injury drives non\u2010traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase","volume":"17","author":"Poole","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1002\/rth2.12403_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/rth2.12403_bb0085","doi-asserted-by":"crossref","first-page":"G226","DOI":"10.1152\/ajpgi.00444.2007","article-title":"Protease\u2010activated receptor 1 knockout reduces experimentally induced liver fibrosis","volume":"294","author":"Rullier","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1002\/rth2.12403_bb0090","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2353\/ajpath.2010.100425","article-title":"The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis","volume":"177","author":"Sullivan","year":"2010","journal-title":"Am J Pathol"},{"issue":"6582","key":"10.1002\/rth2.12403_bb0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/381516a0","article-title":"Role of the thrombin receptor in development and evidence for a second receptor","volume":"381","author":"Connolly","year":"1996","journal-title":"Nature"},{"issue":"6694","key":"10.1002\/rth2.12403_bb0100","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A dual thrombin receptor system for platelet activation","volume":"394","author":"Kahn","year":"1998","journal-title":"Nature"},{"issue":"7783","key":"10.1002\/rth2.12403_bb0105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single\u2010cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1002\/rth2.12403_bb0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0168-8278(01)00285-9","article-title":"Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase\u2010activated receptors","volume":"36","author":"Gaca","year":"2002","journal-title":"J Hepatol"},{"key":"10.1002\/rth2.12403_bb0115","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"issue":"1","key":"10.1002\/rth2.12403_bb0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jth.14641","article-title":"Cell type\u2010specific mechanisms coupling protease\u2010activated receptor\u20101 to infectious colitis pathogenesis","volume":"18","author":"Boucher","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1002\/rth2.12403_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.21834","article-title":"Dose\u2010dependent effects of alpha\u2010naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis","volume":"31","author":"Joshi","year":"2017","journal-title":"J Biochem Mol Toxicol"},{"issue":"8","key":"10.1002\/rth2.12403_bb0130","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.4049\/jimmunol.1303195","article-title":"Hepatic stellate cells orchestrate clearance of necrotic cells in a hypoxia\u2010inducible factor\u20101alpha\u2010dependent manner by modulating macrophage phenotype in mice","volume":"192","author":"Mochizuki","year":"2014","journal-title":"J Immunol"},{"issue":"5","key":"10.1002\/rth2.12403_bb0135","doi-asserted-by":"crossref","first-page":"C1185","DOI":"10.1152\/ajpcell.00126.2002","article-title":"PAR1\u2010dependent and independent increases in COX\u20102 and PGE2 in human colonic myofibroblasts stimulated by thrombin","volume":"284","author":"Seymour","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1002\/rth2.12403_bb0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yjmcc.2018.09.003","article-title":"Factor Xa inhibition by rivaroxaban regulates fibrogenesis in human atrial fibroblasts with modulation of nitric oxide synthesis and calcium homeostasis","volume":"123","author":"Chung","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1002\/rth2.12403_bb0145","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1183\/09031936.04.00005704","article-title":"Thrombin induces collagen gel contraction partially through PAR1 activation and PKC\u2010epsilon","volume":"24","author":"Fang","year":"2004","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1002\/rth2.12403_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.12770","article-title":"Coagulation\u2010driven platelet activation reduces cholestatic liver injury and fibrosis in mice","volume":"13","author":"Joshi","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1002\/rth2.12403_bb0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1679\/aohc1950.41.267","article-title":"Differential staining of collagens type I, II and III by Sirius Red and polarization microscopy","volume":"41","author":"Junqueira","year":"1978","journal-title":"Arch Histol Jpn"},{"issue":"7","key":"10.1002\/rth2.12403_bb0160","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open\u2010source platform for biological\u2010image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"5","key":"10.1002\/rth2.12403_bb0165","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ajpath.2018.01.010","article-title":"Plasminogen activator inhibitor\u20101 reduces tissue\u2010type plasminogen activator\u2010dependent fibrinolysis and intrahepatic hemorrhage in experimental acetaminophen overdose","volume":"188","author":"Pant","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1002\/rth2.12403_bb0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.taap.2017.05.018","article-title":"Von Willebrand factor deficiency reduces liver fibrosis in mice","volume":"328","author":"Joshi","year":"2017","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1002\/rth2.12403_bb0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10620-018-5311-1","article-title":"Dabigatran reduces liver fibrosis in thioacetamide\u2010injured rats","volume":"64","author":"Lee","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1002\/rth2.12403_bb0180","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12088","article-title":"Automated quantification of renal fibrosis with Sirius Red and polarization contrast microscopy","volume":"2","author":"Street","year":"2014","journal-title":"Physiol Rep"},{"issue":"8\u20139","key":"10.1002\/rth2.12403_bb0185","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.clinre.2011.03.011","article-title":"The role of hypercoagulability in liver fibrogenesis","volume":"35","author":"Anstee","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"7","key":"10.1002\/rth2.12403_bb0190","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbadis.2012.12.013","article-title":"Coagulation and coagulation signalling in fibrosis","volume":"1832","author":"Mercer","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1002\/rth2.12403_bb0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/toxsci\/kfw175","article-title":"From the cover: coagulation\u2010driven hepatic fibrosis requires protease activated receptor\u20101 (PAR\u20101) in a mouse model of TCDD\u2010elicited steatohepatitis","volume":"154","author":"Nault","year":"2016","journal-title":"Toxicol Sci"},{"issue":"11","key":"10.1002\/rth2.12403_bb0200","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2003.032136","article-title":"A role for thrombin in liver fibrosis","volume":"53","author":"Duplantier","year":"2004","journal-title":"Gut"},{"issue":"7","key":"10.1002\/rth2.12403_bb0205","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1139\/y97-110","article-title":"Proteinase\u2010activated receptors: structural requirements for activity, receptor cross\u2010reactivity, and receptor selectivity of receptor\u2010activating peptides","volume":"75","author":"Hollenberg","year":"1997","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"10.1002\/rth2.12403_bb0210","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1053\/j.gastro.2007.02.033","article-title":"Gene expression profiles during hepatic stellate cell activation in culture and in vivo","volume":"132","author":"De Minicis","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/rth2.12403_bb0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.102.046391","article-title":"Thrombin and protease\u2010activated receptor\u20101 agonists promote lipopolysaccharide\u2010induced hepatocellular injury in perfused livers","volume":"305","author":"Copple","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1002\/rth2.12403_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086241","article-title":"Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophages","volume":"9","author":"Kallis","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1002\/rth2.12403_bb0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00428-005-0078-0","article-title":"Expression of protease\u2010activated receptors and tissue factor in human liver","volume":"448","author":"Rullier","year":"2006","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1002\/rth2.12403_bb0230","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.ajpath.2011.07.015","article-title":"Protease\u2010activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet","volume":"179","author":"Kassel","year":"2011","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1002\/rth2.12403_bb0235","first-page":"34","article-title":"Contribution of bone marrow\u2010derived fibrocytes to liver fibrosis","volume":"4","author":"Xu","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"10.1002\/rth2.12403_bb0240","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4049\/jimmunol.1401777","article-title":"A brief exposure to tryptase or thrombin potentiates fibrocyte differentiation in the presence of serum or serum amyloid p","volume":"194","author":"White","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"10.1002\/rth2.12403_bb0245","first-page":"265","article-title":"Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat","volume":"74","author":"Tuchweber","year":"1996","journal-title":"Lab Invest"},{"issue":"3","key":"10.1002\/rth2.12403_bb0250","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.24784","article-title":"Protease\u2010activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells","volume":"55","author":"Knight","year":"2012","journal-title":"Hepatology"},{"issue":"12","key":"10.1002\/rth2.12403_bb0255","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/ATVBAHA.111.238261","article-title":"Protease\u2010activated receptor\u20102 modulates protease\u2010activated receptor\u20101\u2010driven neointimal hyperplasia","volume":"31","author":"Sevigny","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"28","key":"10.1002\/rth2.12403_bb0260","doi-asserted-by":"crossref","first-page":"16466","DOI":"10.1074\/jbc.271.28.16466","article-title":"Ligand cross\u2010reactivity within the protease\u2010activated receptor family","volume":"271","author":"Blackhart","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1002\/rth2.12403_bb0265","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","article-title":"Protease\u2010activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR\u2010driven inflammatory diseases","volume":"17","author":"Heuberger","year":"2019","journal-title":"Thromb J"},{"issue":"11","key":"10.1002\/rth2.12403_bb0270","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood-2017-10-810895","article-title":"PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke","volume":"131","author":"Sinha","year":"2018","journal-title":"Blood"},{"key":"10.1002\/rth2.12403_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fendo.2014.00067","article-title":"Biased signaling of protease\u2010activated receptors","volume":"5","author":"Zhao","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1002\/rth2.12403_bb0280","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/ATVBAHA.115.306777","article-title":"Cell\u2010penetrating pepducin therapy targeting PAR1 in subjects with coronary artery disease","volume":"36","author":"Gurbel","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frth2.12403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12403","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:19:30Z","timestamp":1762863570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922020593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2475037922020593"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12403","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver fibrosis is driven by protease\u2010activated receptor\u20101 expressed by hepatic stellate cells in experimental chronic liver injury","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}